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Commentary
Managing chronic pain in elderly patients
requires a CHANGE of approach
Abstract
In many countries, the number of elderly people has increased rapidly in recent years and this is expected to
continue; it has been predicted that almost a quarter of the population in the European Union will be over 65
years of age in 2035. Many elderly people suffer from chronic pain but it is regularly under-treated, partly
because managing these patients is often complex. This paper outlines the extent of untreated pain in this
population and the consequent reduction in quality of life, before articulating the reasons why it is poorly or
inaccurately diagnosed. These include the patient’s unwillingness to complain, atypical pain presentations,
multiple morbidities and cognitive decline. Successful pain management depends upon accurate diagnosis,
which is based upon a complete history and thorough physical examination, as well as an assessment of
psychosocial functioning. Poor physician/patient communication can be improved by using standardized
instruments to establish individual treatment targets and measure progress towards them. User-friendly
observational instruments may be valuable for patients with dementia. In line with the widely accepted
biopsychosocial model of pain, a multidisciplinary approach to pain management is recommended, with
pharmacotherapy, psychological support, physical rehabilitation and interventional procedures available if
required. Declining organ function and other physiological changes require lower initial doses of analgesics
and less frequent dosing intervals, and the physician must be aware of all medications that the patient is
taking, in order to avoid drug/drug interactions. Non-adherence to treatment is common, and various
strategies can be employed to improve it; involving the elderly patient’s caregivers and family, using
medication systems such as pill-boxes, or even sending text messages. In the long term, the teaching of
pain medicine needs to be improved – particularly in the use of opioids – both at undergraduate level and
after qualification.
Introduction
In the Western hemisphere, the elderly population has increased rapidly over
past decades. For example, between 1960 and 1999 the proportion of the
European population aged 60 years rose from 16% to 21%, while the propor-
tion aged 80 years doubled or even tripled in virtually every country1. This
growth is expected to continue; across the 27 European Union member states,
the European Commission predicts that almost a quarter of the population will
be more than 65 years of age by 20352 (Table 1). In the USA, people reaching 65
years of age can expect to live another 18.6 years3. Globally, approximately 10%
of the world’s population is currently aged 65 years, but this is forecast to
exceed 16% by 20504.
Many elderly people experience chronic pain; the prevalence of chronic non-
cancer pain and neuropathic pain increase with age5,6, and by the age of 70 years
pain affects 79% of women and 53% of men7. Managing pain in these patients is
often complex, because of declining organ function, increased vulnerability to
adverse side effects, the presence of comorbidities, and multiple medications8.
Atypical pain presentation and cognitive impairment may further complicate
the picture. Today, pain is frequently under-treated in this age group9,10, yet the
Hans-Georg Kress
Medizinische Universita¨t/AKH Wien, Vienna, Austria
Karsten Ahlbeck
Capio S:t Go¨ran Hospital, Stockholm, Sweden
Dominic Aldington*
Churchill Hospital, Oxford, UK
Eli Alon
Universita¨tsspital Zurich, Zurich, Switzerland
Stefano Coaccioli
Santa Maria General Hospital, Terni, Italy
Flaminia Coluzzi
Department of Anesthesia, Intensive Care and Pain
Therapy, Sapienza University of Rome, Italy
Frank Huygen
University Hospital, Rotterdam, The Netherlands
Wolfgang Jaksch
Schmerzambulanz, Wilhelminenspital der Stadt Wien,
Austria
Eija Kalso
Helsinki University Central Hospital, Finland
Magdalena Kocot-Ke˛pska
Poradnia Leczenia Bo´lu University Hospital, Krako´w,
Poland
Ana Cristina Mangas
Hospital de Santo Andre´, Leiria, Portugal
Cesar Margarit Ferri
Hospital General Universitario de Alicante, Spain
Bart Morlion
University Hospitals Leuven, Belgium
Gerhard Mu¨ller-Schwefe
Schmerz- und Palliativzentrum, Go¨ppingen, Germany
Andrew Nicolaou
St. Georges Hospital, London, UK
Concepcio´n Pe´rez Herna´ndez
Hospital Universitario de la Princesa, Madrid, Spain
! 2014 Informa UK Ltd www.cmrojournal.com Managing chronic pain in elderly patients Kress et al. 1153
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 H
els
ink
i] 
at 
02
:52
 11
 Ja
nu
ary
 20
16
 
demand for satisfactory pain management is increasing dramatically and will
continue to do so.
The CHANGE PAIN initiative was established in 2009 to increase the
understanding of chronic pain among healthcare professionals, to identify
best practice in pain management, and to provide guidance on the treatment
of patients with pain. The international CHANGE PAIN Advisory Board is
composed of pain specialists from Europe and the USA, who were selected on
the basis of their research activity and considerable clinical experience.
At meetings on 9th and 10th December 2011, and 30th and 31st March
2012, Board members considered issues related to the incidence, diagnosis
and treatment of elderly patients with pain, and discussed possible ways of
improving current clinical practice.
Unmet needs
Pain is one of the most prevalent symptoms in elderly people; chronic pain is
reported by approximately 60% of people aged 75 and over in the UK5.
However, studies have consistently shown high levels of untreated or under-
treated pain in this age group11. A recent systematic review of 64 studies found
that the prevalence of chronic pain (i.e. of at least 3 months’ duration) in older
people living in the community ranged from 25% to 76%, and in older people
living in residential care ranged from 83% to 93%12. A 2010 study by Smith et al.
found that unrelieved pain of at least moderate severity was experienced by a
quarter (26%) of older adults (mean age 76 years) during the last 2 years of life,
and this increased to nearly a half (46%) during the last month of life, regardless
of the cause of death13.
Consensus point
Pain is frequently untreated or under-treated in the elderly population.
Consequences of unmet needs
This under-treatment of pain has numerous consequences, many of which con-
tribute to a reduced quality of life. Chronic pain patients exhibit significantly
more mental distress than healthy controls, both when measured by self-rating
and by professional assessment14. Cognitive performance may be affected by
sleep disturbances and impaired emotional decision-making15,16, as a result of
structural changes and behavioral deficits in cortical areas of the brain caused by
chronic pain17. Many people with chronic pain report that it severely affects
their ability to exercise, walk, carry out household chores and maintain an
independent lifestyle18. The fact that patients with chronic pain are signifi-
cantly more fatigued than healthy controls19 often leads to a decline in com-
munal activities and social isolation. The resultant loneliness is one of the main
factors leading to depression20, and these individuals experience higher levels of
chronic pain than those who receive adequate social support21. In the elderly,
the impact of these limitations is often greater, and may be compounded by a
heavier burden being imposed upon caregivers.
Pain in the elderly: Europe today
The National Health and Wellness Survey (NHWS) is an internet-based, cross-
sectional study of the healthcare attitudes, behaviors and characteristics of the
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adult population in various countries, which is regularly
conducted by Kantar Health of Princeton, New Jersey,
USA. Core reports are produced for each country and
the data obtained are analyzed according to a range of
different parameters. The present analysis is based on the
2010 NHWS for the United Kingdom, France, Spain,
Germany and Italy. The results are not inconsistent with
previous estimates of the prevalence of pain in a much
broader range of countries, but direct comparisons are dif-
ficult because different study designs, assessment methods
and definitions of pain have been employed.
The prevalence of pain categorized as moderate or
severe was highest in the 40–59 year age group, and mild
pain was most common in the 18–39 year age group22. Of
the 9963 survey participants who were aged465 years,
2083 (21%) reported experiencing pain during the last
month (Table 2)22. The proportion of women with pain
in this age group was more than twice as high as the pro-
portion of men with pain (68%:32%). Of these older
respondents with pain, the intensity was rated as severe,
moderate or mild by 15%, 65% and 20%, respectively. The
prevalence of depression increased progressively with the
severity of pain, but was much more common among
respondents below the age of 65 years than those 465
years. The majority of respondents with moderate or
severe pain were receiving prescription analgesics, but
the proportions were higher in the older age group: 86%
and 70% for those with severe and moderate pain, respect-
ively, compared with 81% and 56%, respectively, for the
younger age group22.
Healthy ageing
Chronic pain is a substantial burden on individuals and
society, has a major impact on healthy ageing, and incurs
enormous costs for healthcare systems. A systematic litera-
ture review by Kleijnen Systematic Reviews Ltd, commis-
sioned by Gru¨nenthal GmbH, found a clear correlation
between the severity of pain and reduced quality of life
(QoL)23. Furthermore, it revealed that the prevention
and treatment of chronic pain are likely to improve QoL
and could increase healthy lifespan by 2 years, which is one
objective of the European Union’s Active and Healthy
Ageing Partnership project. The European Federation of
IASP Chapters (EFIC) recently called for European Ta
bl
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Table 1. Projected population of the 27 European Union member states2.
Percentage aged 65þ Percentage aged 80þ
2008 2035 2060 2008 2035 2060
EU27 17.1 25.4 30.0 4.4 7.9 12.1
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governments and EU institutions to address the issues asso-
ciated with untreated and undertreated pain, and this has
since been endorsed by 58 organizations, including many
national pain societies.
The challenge of diagnosis
There are various reasons why pain in elderly patients is
often not diagnosed or inaccurately diagnosed. Firstly, they
may fail to report their pain because they believe it is
normal in old age, they are afraid it may lead to more
diagnostic testing or loss of independence24,25, or because
an accumulation of health-deteriorating factors means
that a single factor (i.e. pain) gradually assumes a lower
impact on self-rated health26. This unwillingness to com-
plain may be compounded by the misconception among
some healthcare professionals – for which there is no sci-
entific basis – that the elderly have a reduced perception of
pain compared with younger people25. Secondly, elderly
patients – particularly those of most advanced age – may
exhibit atypical pain presentations as a symptom of acute
disease27. Thirdly, multiple comorbidities are extremely
common, and have a negative impact on patients’ physical
health and emotional, cognitive, and functional status28.
For the clinician, comorbidities strongly influence the
diagnostic process by modifying the presentation of coex-
istent conditions28. Fourthly, a particular problem is pre-
sented by patients whose capacity to communicate and
remember has been reduced by cognitive decline, so that
they are unable to provide an accurate picture of their
symptoms. A further complication is that the brains of
patients with Alzheimer’s disease (AD), vascular dementia
and frontotemporal dementia all exhibit atrophy and
white matter lesions, but variations in severity and the
areas affected mean that AD and frontotemporal dementia
may be associated with increased levels of pain, but in
vascular dementia these may be reduced29. Dementia is
related to a lower prevalence of reported pain and anal-
gesic use30,31. The reasons for this are complex, but include
the use of inadequate methods to assess and document
pain, a reluctance to use opioids, and physicians’ misun-
derstanding of the physiological and psychological compo-
nents of pain32.
From the clinical perspective, one factor contributing
to under-diagnosis may be that the International
Classification Of Diseases-10 (ICD-10) – which serves as
the worldwide basis for the classification of diagnoses –
does not include the diagnosis ‘chronic pain’.
Furthermore, if a patient presents with pain requiring
medical attention, the physician has to search multiple
categories of the ICD-10 to find an adequate diagnosis,
and recognition of the uniqueness of pain conditions is a
precondition for adequate treatment33.
Consensus point
There is a misconception among some healthcare pro-
fessionals that elderly people have a reduced percep-
tion of pain and/or that pain is a normal consequence
of ageing.
Improving pain diagnosis in the elderly
patient
The complexity of pain assessment in elderly patients
with chronic pain frequently requires a multidisciplinary
approach to diagnosis. In particular, collaboration with
a psychiatrist or psychologist has been recommended
because of the possibility of depression, and also with a
physical therapist, to help with functionality34.
The cornerstone of accurate diagnosis is a thorough
examination that incorporates a complete history and
physical examination, focusing on the patient’s experience
of pain. The location, character, frequency and intensity of
the pain should be recorded, together with any exacerbat-
ing or alleviating factors and its effect on mood and sleep.
Assessments should be made of any depression or cognitive
impairment, the patient’s gait and balance, and his or her
level of physical functioning, as demonstrated by activities
of daily living (ADLs). Psychosocial functioning can be
estimated from the patient’s relationship with relatives,
social support groups and caregivers. The examination
should be followed by any pertinent laboratory or diagnos-
tic tests to identify the cause and subsequent pathophysi-
ology of the pain. These investigations are important,
because treatment strategies targeted at specific underlying
mechanisms are likely to be most effective35.
Standardized instruments
In order to achieve a common understanding of the
patient’s pain experience – as well as the proposed ther-
apy and expected outcome – effective physician/patient
communication is essential. This communication is often
compromised in elderly patients. Where this is the case,
much valuable information can be obtained from care-
givers and close relatives. Standardized instruments can
improve communication and provide a greater insight
into patients’ pain. Unidimensional instruments such as
the Numeric Rating Scale (NRS) and Visual Analogue
Scale (VAS) can be used for many elderly patients,
while more information can be obtained from multidimen-
sional instruments. Examples of these include the McGill
Pain Questionnaire (MPQ), which provides a quantitative
measure of subjective pain experience from an intensity
Current Medical Research & Opinion Volume 30, Number 6 June 2014
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scale and three categories of word descriptors36, and the
CHANGE PAIN Scale, which records not only the cur-
rent and target pain intensity, but also the improvement
required in six key parameters that affect QoL37. Patients
differ enormously both in their symptoms and what they
consider to be an acceptable level of pain; these instru-
ments can help in establishing individual treatment targets
and measuring progress towards them37.
Patients with dementia
In patients with advanced dementia, an inability to
communicate may be compounded by atypical and idio-
syncratic physical and psychological behavior, which
makes pain assessment extremely difficult. It should be
noted, however, that stimulus detection and pain thresh-
old are preserved in Alzheimer’s Disease, even though
anticipation and autonomic reactivity are severely
affected38. A number of user-friendly observational instru-
ments have been developed to measure pain in these
patients, such as the Pain Assessment in Advanced
Dementia Scale (PAINAD) and the Pain Assessment
Checklist for Seniors with Limited Ability to
Communicate (PACSLAC). The PAINAD consists of
five items (breathing, negative vocalization, facial expres-
sion, body language and consolability) that are each scored
from 0 to 2, giving a range of results from 0 (no pain) to 10
(severe pain). The four subscales of the PACSLAC cover:
(i) social, personality and mood indicators, (ii) facial
expressions, (iii) activity and body movement, and (iv)
physiological and other factors, including eating, sleep
changes and vocalizations. The observer marks 60 items
that indicate subtle changes in behavior as being present or
absent, and the total score appears to discriminate between
painful, calm and distressing events39.
Consensus point
Standardized instruments can improve physician/
patient communication and understanding of the
patient’s pain experience.
Painvision
One innovative technology currently being developed in
Belgium is Painvision. This utilizes the fact that facial
expression is an important indicator of pain in patients
with dementia, and that their facial responses are closely
related to the intensity of noxious stimulation40. During
normal nursing care, facial expressions are not continu-
ously monitored and their interpretation is not objective.
Painvision is a visual system consisting of two synchro-
nized video recording cameras and a wi-fi computer net-
work which can continually identify discomfort in real
time, and will ultimately be able to alert a caregiver via
the Internet41.
Improving pain management in the elderly
patient
General principles
The widely accepted biopsychosocial model considers pain
to be an interactive, psychophysiological behavior pattern
that cannot be separated into distinct, independent psy-
chosocial and physical components42. It therefore follows
that a multidisciplinary approach is recommended to
investigate all possible options for optimal management,
including (1) pharmacotherapy, (2) psychological support,
(3) physical rehabilitation, and (4) interventional proced-
ures34. A number of studies and reviews have shown this
approach to be more effective than standard, non-multi-
disciplinary care in reducing pain and emotional distress,
and improving function43–46. Ideally, multidisciplinary
care should also involve the patient’s family and any
carers, and be adapted to the patient’s individual needs.
Particular caution should be exercised where the patient is
being treated on an outpatient basis and lives alone. In this
situation, the possible side effects of powerful analgesics –
and their consequences – must be taken into consider-
ation. The absence of a carer or suitable family member
may also limit the range of potential treatments; for exam-
ple, transcutaneous electrical nerve stimulation (TENS)
may be excluded if there is nobody to help attach the
electrodes.
Pain is not a homogeneous sensory entity. Several dis-
tinct types exist which are produced by a range of mech-
anisms, including nociception, peripheral sensitization,
central sensitization, ectopic excitability, structural
reorganization and decreased inhibition47–50. The same
painful symptom may be generated by a number of mech-
anisms, and a single mechanism can produce different
symptoms, ranging from paresthesia to spontaneous
burning pain51. Not all patients with chronic pain
have similar mechanisms and intensity does not reflect
the neurobiological causes, only the extent to which
they are activated52. For pharmacological therapy,
therefore, it is rational to use agents which address the
likely causative mechanisms wherever possible. For exam-
ple, the induction of cyclooxygenase-2 (COX-2) contrib-
utes substantially to the pain of most inflammatory
conditions, so COX-2 inhibitors have a clear role here.
However, these agents offer no benefit in diabetic periph-
eral neuropathy, where nerve injury leads to abnormal
sodium channel activity and pain is mainly due to ectopic
excitability53,54.
Psychological support aims to address anxiety, stress
and depression by giving patients some control over their
Current Medical Research & Opinion Volume 30, Number 6 June 2014
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pain, and may include strategies such as psychotherapy,
stress management, relaxation training, biofeedback and
behavior modification. Counseling patients and educating
them about their conditions and the anticipated outcomes
can also prove valuable55. The aim of physical rehabilita-
tion is to improve physical function and help the patient
to live a more independent life. It may include such elem-
ents as physiotherapy, graded exercises, postural control,
pacing strategies, and functional movement to improve
motor control. It is strongly recommended by the
American Society of Anesthesiologists for the relief of
low back pain56. Interventional procedures – such as
nerve blocks – can help the clinician to arrive at a pre-
cise diagnosis and may allow lower doses of medication
to be prescribed34.
Declining organ function
Organ function progressively declines with the passage of
time. Between 30 years and extreme old age, there are
decreases of approximately 50% or more in vital capacity,
glomerular filtration rate, renal plasma flow and maximal
breathing capacity (Figure 1)57. The function of the
gastrointestinal, hemopoetic and immune systems also
declines58,59. These physiological changes may affect
drug metabolism60 and the risk of an adverse drug reaction
is greater in elderly patients61. Drugs with anticholinergic
activity may accelerate cognitive decline62. Opioids may
be associated with a higher incidence of adverse events
than previously thought, including cardiovascular events,
acute kidney injury and fractures63, although the risk
varies by opioid, adverse event and treatment duration64.
Prescription is further complicated by the increasing inter-
individual variability in drug metabolism, drug action and
adverse reactions that is a feature of advancing age, par-
ticularly when accompanied by frailty65. The clinician
must take this altered physiology into account when assess-
ing potential toxicity and response to treatment.
Consensus point
Physiological changes must be taken into account
when prescribing drugs for elderly patients.
Pharmacokinetic changes include a reduction in renal and
hepatic clearance and an increase in the volume of distri-
bution of lipid-soluble drugs, which prolong the elimin-
ation of pharmaceutical agents66. Pharmacodynamic
changes involve altered sensitivity to several classes of
drugs, including anticoagulants, cardiovascular and psy-
chotropic agents, which often increases their effect66 and
the likelihood of side effects. Therefore, a lower than
normal initial dose should be considered when prescribing
a new medication to an elderly patient, together with less
frequent dosing intervals and slow adjustment of the
dosage to achieve the optimum therapeutic effect67,68.
This approach can be summed up by the adage ‘start low,
go slow and follow up’. A long-term view with frequent
monitoring and follow up is very important, to reassess the
response to therapy and to avoid either overdosing or
under-treatment.
Consensus point
The ‘start low, go slow and follow up’ approach should
be considered when prescribing medication to elderly
patients.
The least invasive route of administration should be
used69; the oral route may be the most convenient and it
can rapidly provide relatively steady blood concentrations,
but transdermal administration may be preferred for some
patients. The advantages and disadvantages of the two
routes (if available) should be routinely evaluated for
each patient.
The application of technology can assist in clinical
decisions regarding the dosage of drugs in individual
patients. For example, computerized provider order entry
(CPOE) systems, where the prescriber personally enters
the prescription into a computer and the prescription is
then transmitted to the pharmacy70, can recommend the
adjustment required to allow for impaired renal function.
Some classes of drugs should be used with extreme cau-
tion in elderly patients as a result of age-related changes.
Because this age group is most likely to develop delirium, it
is important to avoid drugs that might increase the risk of
this adverse event. A literature review on the association
between medications and delirium found that benzodi-
azepines, opioids, dihydropyridines and antihistamines
0
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Figure 1. The decline in organ function with age. Adapted with permission
from Fries (2000)57.
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appear to be associated with an increased risk of delirium,
but concluded that in the case of opioids caution should be
tempered with the observation that untreated severe
pain can itself cause delirium71. In its revised guidelines
for managing pain in older persons published in 2009,
the American Geriatric Society recommends that
non-steroidal anti-inflammatory drugs (NSAIDs) and
COX-2 selective inhibitors ‘‘may be considered rarely,
and with extreme caution, in highly selected individ-
uals’’69, citing their association with adverse events includ-
ing gastrointestinal toxicity72 (which increases in
frequency and severity with age73), and interference with
renal function74,75. Furthermore, all patients taking these
drugs should be routinely assessed for gastrointestinal and
renal toxicity, hypertension, heart failure, and other drug–
drug and drug–disease interactions69. Acetaminophen is
recommended for patients with mild to moderate persist-
ent pain, especially musculoskeletal pain, while opioid
therapy should be considered for ‘‘all patients with moder-
ate to severe pain, pain-related functional impairment or
diminished quality of life due to pain’’69.
When prescribing opioids, it should be borne in mind
that with all these agents – except buprenorphine – the
half-life of the active drug and metabolites is increased in
the elderly and in patients with renal dysfunction76. It is
therefore recommended that doses should be reduced, a
longer time interval be used between doses, and creatinine
clearance be monitored76. Thus buprenorphine appears to
be the first-line choice for opioid treatment in the elderly.
However, the fact that it is a partial agonist at the m-opioid
receptor has implications for patients being switched to
buprenorphine from a pure m-opioid agonist, such as mor-
phine or oxycodone. If the switch is made abruptly, the
patient may experience withdrawal symptoms such as
sweating, anxiety, insomnia, tachycardia, nausea, abdom-
inal cramps and muscle pains. To prevent this, a tapering
schedule should be used; the dose of the pure m-opioid
agonist is decreased by about 20–25% every day or two,
while the dose of buprenorphine is simultaneously titrated
upwards.
The opioid methadone requires special caution in eld-
erly patients. Its analgesic effect lasts only 6 to 8 hours,
which is much shorter than its half-life of 16 to 30 hours, so
the repeated dose required for pain relief can result in
accumulation of the drug in patients with reduced hepatic
and renal function77.
Clinicians should also be aware that opioid use is asso-
ciated with an increased risk of injury and fractures, which
is dose-dependent and higher for short-acting opioids than
long-acting opioids, especially during the first 2 weeks of
therapy78–80. It is generally believed that the increased risk
is a result of side effects such as dizziness, sedation, light-
headedness and nausea leading to a greater number of falls,
but some researchers have suggested that opioids might
also interfere with bone formation through suppression
of endogenous sex hormone production81. Coanalgesics
such as pregabalin, gabapentin and tricyclic antidepres-
sants – which can themselves produce dizziness and sed-
ation – may further compound the risk.
Comorbidities and polypharmacy
The presence of multiple comorbidities is particularly
striking in those of very advanced age; 31% of patients
aged 85 years have 4 chronic disorders82. To treat
these, many elderly people receive polypharmacy, with
the attendant risk of drug/drug interactions that increases
exponentially with the number of medications taken83.
It has been shown that about two-thirds of community-
dwelling people aged460 years take four or more medica-
tions daily, frail elderly people with multiple comorbidities
take an average of nine84, and elderly hospital in-patients
may be prescribed as many as fourteen83. The probability of
interactions may be further increased by the consumption
of over-the-counter (OTC) medications, which many
patients perceive to be unimportant and do not disclose
to their physician. One study of community-dwelling indi-
viduals aged 57 to 85 years found that 46% of those receiv-
ing at least one prescription drug were concurrently taking
OTC medications, and 52% were concurrently taking
dietary supplements85. Thus it is important to be aware
of all the medications that the patient is taking – including
over-the-counter preparations – and the doses of each.
Consensus point
Polypharmacy is common in elderly patients, leading
to an increased risk of drug/drug interactions and ser-
ious adverse events.
Interactions between drugs can lead to serious adverse
events or a reduction in therapeutic effect. In pharmaco-
dynamic interactions, two or more drugs directly influence
each other’s effects, whereas pharmacokinetic interactions
involve the reciprocal influencing of absorption, distribu-
tion, metabolism and elimination, altering the effective
concentration of the drugs at their sites of action86.
Common drug/drug interactions in elderly patients include
(i) aspirin with ibuprofen or naproxen, increasing the car-
diac risk of patients with coronary heart disease, (ii)
NSAIDs with angiotensin-converting enzyme (ACE)
inhibitors giving elevated serum potassium levels and pos-
sible renal failure, or with COX-2 inhibitors, increasing
the risk of gastrointestinal bleeding, and iii) combinations
of drugs acting on the CNS, leading to sedation, confusion
and falls86,87.
To minimize the risk of interaction with multiple medi-
cations and serious adverse events, both the route of
administration and the specific agents prescribed should
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be considered. In some circumstances, the slow increase in
serum concentration offered by transdermal administra-
tion of fentanyl or buprenorphine may be advantageous;
for example, the time to minimum therapeutic concentra-
tion of transdermal buprenorphine is 21 hours88. This
route avoids wide variations in drug concentration,
which are less well tolerated by elderly patients, in line
with World Health Organization guidelines. Of particular
relevance to this age group, it offers ease of application and
can be used when elderly patients are unable to tolerate, or
unwilling to swallow, oral medication. However, care must
be taken not to initiate treatment at too high a dose89, as
this can increase the likelihood of serious adverse events,
especially in patients who are opioid-naı¨ve.
Before initiating pharmacological treatment, a thor-
ough assessment of all medications should be conducted
and an effort made to reduce the number, if possible90.
When prescribing a particular class of analgesic, it may
be possible to reduce the risk of subsequent drug/drug inter-
actions by matching the specific agent to the patient’s
physiology and existing medication. For example, age-
related decline in cytochrome P-450 function may
increase the risk of toxic interactions; selective serotonin
reuptake inhibitors (SSRIs) inhibit the cytochrome system
and can lead to an accumulation of narcotic agents if the
two drugs are administered concurrently34. For example,
tramadol is partly a prodrug, its analgesic action depending
on both the parent drug and the M1 metabolite (O-des-
methyltramadol). If demethylation of the parent drug via
the cytochrome P-450 system is decreased by simultaneous
administration of an SSRI, then analgesia may be reduced
and the parent drug can accumulate. As the combined
serotonergic activity of tramadol and the SSRI may be at
least additive, the risk of a potentially fatal serotonin syn-
drome is increased. If an opioid is required and the current
drug regime indicates a possible cytochrome P-450 inter-
action, then morphine, hydromorphone, oxymorphone or
tapentadol should be considered, because these are not
metabolized by the cytochrome P-450 system. For tapen-
tadol, no clinically relevant drug–drug interactions are
likely to occur through induction or inhibition of cyto-
chrome P450 enzymes or plasma protein binding91. If the
glomerular filtration rate is reduced, however, then bupre-
norphine is an attractive option as it is excreted mainly via
the liver, avoiding potentially high serum levels of
opioid76.
Adherence/compliance
Estimates of the extent of non-adherence in the elderly
vary from 40% to 75% and there are three common
forms92. Some older patients take more than the prescribed
dose in the mistaken belief that this will have a greater
beneficial effect. Forgetting to take a dose is common,
particularly when there is cognitive decline or the patient
has been prescribed multiple medications. Most frequent is
under-use; inappropriate drug discontinuation may occur
in up to 40% of patients, particularly within the first year of
a chronic care regimen92.
Various strategies can be used to improve adherence in
elderly patients. Communication between physician and
patient should be optimized as far as possible to enable
educational interventions. Where the patient is living in
the community, it is important to involve any caregivers
and the patient’s family in the provision of practical sup-
port, providing relations within the family are good.
Adherence is 1.74 times better in patients from cohesive
families, but 1.53 times worse when the family is in
conflict93.
Consensus point
It is important to involve any caregivers and the
patient’s family in the provision of practical support,
providing that relations within the family are good.
Emphasizing the value of the drug regimen and the benefit
of adherence has been shown to be effective in improving
adherence94. In one study of elderly patients leaving hos-
pital, by 12 weeks after discharge half the patients were
initially taking fewer than half the prescribed tablets, and a
further quarter were seriously overdosing themselves95.
However, a 15 minute counseling session was found to
be highly effective in reducing medication errors, even
in confused patients95. The patient should be provided
with clear instructions and the dosing regimen simplified
as far as possible; for example, by using drugs with longer
half-lives to reduce the number of medications and facili-
tate daily dosing, and by customizing the timing of doses to
match the patient’s lifestyle96. The use of medication-
taking systems (e.g. pill-boxes) to organize daily doses
can reduce errors, while the attendance of community-
based patients (and thus adherence) can be improved by
making clinical appointments as convenient and efficient
for them as possible96. With the increasing integration of
technology into patient care and society in general, the
sending of daily text messages to remind patients to take
medication has been shown to improve adherence rates in
healthy young women using oral contraceptives97, and this
method may be transferable to elderly patients.
Elderly patients are more vulnerable to medication-
related problems than younger ones, because of the
dosage adjustment required by pharmacokinetic and phar-
macodynamic changes, as well as the presence of comor-
bidities and polypharmacy67. The majority of medication
errors are preventable98. Most are due to prescribing faults
(failure in deciding the correct drug to use and how) or
prescription errors (providing incorrect instructions), and
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one way of reducing the number is by the application of
technology. CPOE systems not only guarantee legibility
and avoidance of transcription errors, they can also
ensure the completeness and accuracy of prescriptions99.
In studies, CPOE has decreased the incidence of medica-
tion errors by 55%100 and 95.9%101. A similar benefit
(490% reduction in dispensing errors) has been achieved
by introducing a barcode-enabled point-of-care (BPOC)
system102. This involves scanning a patient’s barcoded
wristband and the barcode on the intended individual
drug dose. Relevant patient information is then displayed
on a laptop computer, which also compares the proposed
dose with the patient’s drug regimen – in the event of any
mismatch, an alert appears on the screen.
Education
For the various measures outlined above to be widely
implemented, there needs to be an improvement in the
teaching of pain medicine. For example, opioids remain
the drugs of choice for the treatment of moderate to severe
pain103, but the appropriate use of these agents is often
restricted by barriers such as a fear of abuse and addiction,
particularly in developing countries103. Misconceptions
held by healthcare professionals are often a major factor
in the under-use of opioids. There are widespread concerns
about opioid addiction, tolerance and hyperalgesia, as well
as unrealistic anxieties about precipitating adverse side
effects and an unfounded assumption that long-term
opioid treatment necessarily impairs patients’ quality of
life103. This should not be altogether surprising, as phys-
icians responding to surveys acknowledge that they have
received insufficient training in opioid pharmacology and
pain management in general104,105. The need for improved
training is even more marked in the case of elderly
patients, where accurate diagnosis and the satisfactory
management of pain present particular challenges, and
require higher levels of expertise.
Firstly, there should be a greater emphasis on pain man-
agement in the medical undergraduate curriculum. For
example, the median time spent on pain management by
a UK medical student is 13 hours, and in some cases as
little as 6 hours106. Furthermore, the subject is taught
piecemeal and not as a separate module106. Continuing
medical education (CME), such as the PAIN
EDUCATION Program offered as part of the CHANGE
PAIN initiative, also has a vital role to play. Currently, six
CME modules have been developed – on topics such as
mechanisms of pain and the multimodal management of
chronic pain – and are available online in several
European languages. They are accredited by the Union
Europe´enne des Me´decins Spe´cialistes (UEMS) and vari-
ous national bodies. A new module dealing specifically
with pain in the elderly is almost complete, and will
soon be available from the CHANGE PAIN website
(http://www.change-pain.com).
Conclusions
Many elderly people have chronic pain, but studies have
consistently shown high levels of untreated or under-trea-
ted pain in older people which adversely affects their qual-
ity of life. The reasons for this include the failure by
patients to report pain and the misconception among
some healthcare professionals that the elderly have a
reduced perception of pain. Also, pain management is
often challenging in these patients because of declining
organ function, impaired cognition, the presence of
comorbidities, increased vulnerability to side effects, and
polypharmacy. In the developed world, the proportion of
elderly people in the population has risen dramatically in
recent years and this is expected to continue, so the need
to improve pain management for this age group is becom-
ing increasingly urgent.
A number of different approaches could prove benefi-
cial. Standardized instruments can improve communica-
tion and help diagnose patients’ pain. A ‘start low, go slow
and follow up’ approach should be considered when pre-
scribing medications to elderly patients. The number of
prescribing faults and prescription errors can be reduced
by the introduction of technology, such as CPOE and
BPOC systems. Non-adherence levels in elderly patients
are currently high, but these could be improved by coun-
seling on the benefits of treatment, simplifying dosage regi-
mens, and utilizing medication-taking systems.
Finally, in order to increase awareness among the med-
ical community of how pain management can be
improved, there needs to be better teaching of pain medi-
cine – particularly with respect to the use of opioids – both
at undergraduate level and post-qualification.
Transparency
Declaration of funding
Funding for this study was provided by Gru¨nenthal GmbH.
Declaration of financial/other relationships
All authors are members of the CHANGE PAIN International
Advisory Board. As such, they have received honoraria for
attending the meetings upon which this paper is based. In add-
ition, H.-G.K. and G.M.-S. declare that they are chairmen of the
International Advisory Board on CHANGE PAIN for
Gru¨nenthal GmbH, and receive honoraria in this context.
None of the authors received honoraria for the writing of this
paper.
CMRO peer reviewers may have received honoraria for their
review work. The peer reviewers on this manuscript have dis-
closed that they have no relevant financial relationships.
Current Medical Research & Opinion Volume 30, Number 6 June 2014
! 2014 Informa UK Ltd www.cmrojournal.com Managing chronic pain in elderly patients Kress et al. 1161
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 H
els
ink
i] 
at 
02
:52
 11
 Ja
nu
ary
 20
16
 
Acknowledgments
Medical writing support was provided by Derrick Garwood of
Derrick Garwood Ltd, Cambridge, UK, and was funded by
Gru¨nenthal GmbH.
References
1. Pearce D. The demographic situation in the European Union. Population
Trends 2001;104:6-11
2. European Commission. Population projections 2008–2060. Available at:
http://europa.eu/rapid/press-release_STAT-08-119_en.htm [Last accessed
15 October 2013]
3. Administration on Aging. A Profile of Older Americans: 2009. U.S. Department
of Health and Human Services. Available at: http://www.aoa.gov/aoaroot/
aging_statistics/profile/2009/docs/2009profile_508.pdf [Last accessed 2
April 2013]
4. WP 2. Analysis of Needs. Final Report. 2010 Nurse Managed Care for Elderly
Project Team, 2010. Available at: http://www.nmce.eu/images/stories/
articles/analysis_of_needs_en.pdf [Last accessed 3 April 2012]
5. Elliott AM, Smith BH, Penny KI, et al. The epidemiology of chronic pain in the
community. Lancet 1999;354:1248-52
6. Dieleman JP, Kerklaan J, Huygen FJ, et al. Incidence rates and treatment of
neuropathic pain conditions in the general population. Pain 2008;137:681-8
7. Bergh I, Steen G, Waern M, et al. Pain and its relation to cognitive function and
depressive symptoms: a Swedish population study of 70-year-old men and
women. J Pain Symp Manag 2003;26:903-12
8. Rao A, Cohen HJ. Symptom management in the elderly cancer patient:
fatigue, pain, and depression. J Natl Cancer Inst Monogr 2004;32:150-7
9. Robinson CL. Relieving pain in the elderly. Health Prog 2007;88:48-53
10. Gianni W, Madaio RA, Di Cioccio L, et al. Prevalence of pain in elderly
hospitalized patients. Arch Gerontol Geriatr 2010;51:273-6
11. Cassel KC. Geriatric medicine: an evidence-based approach. New York, USA:
Springer, 2003
12. Abdulla A, Adams N, Bone M, et al. Guidance on the management of pain in
older people. Age Ageing 2013;42:i1-57
13. Smith AK, Cenzer IS, Knight SJ, et al. The epidemiology of pain during the last
2 years of life. Ann Intern Med 2010;153:563-9
14. Gormsen L, Rosenberg R, Bach FW, et al. Depression, anxiety, health-related
quality of life and pain in patients with chronic fibromyalgia and neuropathic
pain. Eur J Pain 2010;14:127.e1-8
15. Apkarian AV, Sosa Y, Krauss BR, et al. Chronic pain patients are impaired on
an emotional decision-making task. Pain 2004;108:129-36
16. Baliki MN, Chialvo DR, Geha PY, et al. Chronic pain and the emotional brain:
specific brain activity associated with spontaneous fluctuations of intensity of
chronic back pain. J Neurosci 2006;26:12165-73
17. Apkarian AV, Sosa Y, Sonty S, et al. Chronic back pain is associated with
decreased prefrontal and thalamic gray matter density. J Neurosci
2004;24:10410-15
18. Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe:
prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333
19. Fishbain DA, Cutler RB, Cole B, et al. Are patients with chronic low back pain
or chronic neck pain fatigued? Pain Med 2004;5:187-95
20. Green BH, Copeland JR, Dewey ME, et al. Risk factors for depression in elderly
people: A prospective study. Acta Psychiatr Scand 1992;86:213-17
21. Phillips JM, Gatchel RJ. Extraversion–introversion and chronic pain: locus
of control in the patient with chronic pain. In: Gatchel R, Weisberg J (eds).
Personality Characteristics of Patients with Pain. Washington DC: American
Psychological Association, 2000:181-202
22. Kantar Health Inc. National Health And Wellness Survey, 2010 [EU]. Princeton,
NJ, USA, 2010
23. Leadley RM, Armstrong N, Reid KJ, et al. Healthy aging in relation to chronic
pain and quality of life in Europe. Pain Pract 2013: published online
21 October 2013, doi:10.1111/papr.12125
24. AGS Panel on Persistent Pain in Older Persons. The management of persistent
pain in older persons. J Am Geriatr Soc 2002;50(6 Suppl):S205-24
25. Iyer PW. Medical–legal aspects of pain and suffering. Tucson, Arizona:
Lawyers & Judges Publishing Company Inc., 2005
26. Ma¨ntyselka¨ PT, Turunon JHO, Ahonen RS, et al. Chronic pain and poor self-
rated health. J Am Med Assoc 2003;290:2435-42
27. Mostofsky DI, Lomranz J. Handbook of pain and aging. Basel, Switzerland:
Birkha¨user, 1997
28. Leong IY, Farrell MJ, Helme RD, et al. The relationship between
medical comorbidity and self-rated pain, mood disturbance, and function
in older people with chronic pain. J Gerontol A Biol Sci Med Sci
2007;62:550-5
29. Scherder EJA, Sergeant JA, Swaab DF. Pain processing in dementia and its
relation to neuropathology. Lancet Neurol 2003;2:677-86
30. Morrison RS, Siu AL. A comparison of pain and its treatment in advanced
dementia and cognitively intact patients with hip fracture. J Pain Symptom
Manage 2000;19:240-8
31. Ma¨ntyselka¨ P, Hartikainen S, Louhivuori-Laako K, et al. Effects of dementia on
perceived daily pain in home-dwelling elderly people: a population-based
study. Age Ageing 2004;33:496-9
32. Schilling ML. Pain management in older adults. Curr Psychiatry Rep
2003;5:55-61
33. Rief W, Kaasa S, Jensen R, et al. New proposals for the International
Classification of Diseases-11 revision of pain diagnoses. J Pain
2012;13:305-16
34. Kaye AD, Baluch A, Scott JT. Pain management in the elderly population: a
review. Ochsner J 2010;10:179-87
35. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological
mechanisms, and treatment. Lancet 2010;9(8):807-19
36. Melzack R. The McGill Pain Questionnaire: major properties and scoring
methods. Pain 1975;1:277-99
37. Mu¨ller-Schwefe G, Jaksch W, Morlion B, et al. Make a CHANGE: optimising
communication and pain management decisions. Curr Med Res Opin
2011;27:481-8
38. Benedetti F, Arduino C, Vighetti S, et al. Pain reactivity in Alzheimer patients
with different degrees of cognitive impairment and brain electrical activity
deterioration. Pain 2004;111:22-9
39. Zwakhalen SMG, Hamers JPH, Abu-Saad HH, Berger MPF. Pain in elderly
people with severe dementia: a systematic review of behavioural pain assess-
ment tools. BMC Geriatrics 2006;6:3. doi:10.1186/1471-2318-6-3
40. Kunz M, Scharmann S, Hemmeter U, et al. The facial expression of pain in
patients with dementia. Pain 2007;133:221-8
41. Painvision. Monitoring of discomfort in demented elderly patients based on
automatic image recognition. Available at: http://project.mobilab.be/painvi-
sion/index.html. [Last accessed 7 May 2012]
42. Turk DC, Monarch ES. Biopsychosocial perspective on chronic pain. In: Turk
DC, Gatchel RJ (Eds). Psychological Approaches to Pain Management:
A Practitioner’s Handbook. New York, USA: Guilford, 2002
43. Guzman J, Esmail R, Karjalainen K, et al. Multidisciplinary rehabilitation for
chronic low back pain: a systematic review. BMJ 2001;332:1511-16
44. Scascighini L, Toma V, Dober-Spielmann S, et al. Multidisciplinary treatment
for chronic pain: a systematic review of interventions and outcomes.
Rheumatology 2008;47:670-8
45. Gatchel RJ, McGeary DD, Peterson A, et al. Preliminary findings of a rando-
mized controlled trial of an interdisciplinary military pain program. Mil Med
2009;174:270-7
46. Roditi D, Robinson ME. The role of psychological interventions in the
management of patients with chronic pain. Psychol Res Behav Manag
2011;4:41-9
47. Mogil JS, Yu I, Busbaum AI. Pain genes?: natural variation and transgenic
mutants. Annu Rev Neurosci 2000;23:777-811
48. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science
2000;288:1765-9
49. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature
2001;413:203-10
Current Medical Research & Opinion Volume 30, Number 6 June 2014
1162 Managing chronic pain in elderly patients Kress et al. www.cmrojournal.com ! 2014 Informa UK Ltd
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 H
els
ink
i] 
at 
02
:52
 11
 Ja
nu
ary
 20
16
 
50. Scholz J, Woolf CJ. Can we conquer pain? Nat Neurosci 2002;
5(Suppl):1062-7
51. Woolf CJ, Max MB. Mechanism-based pain diagnosis: issues for analgesic
drug development. Anesthesiol 2001;95:241-9
52. Woolf CJ. Pain: moving from symptom control toward mechanism-specific
pharmacologic management. Ann Intern Med 2004;140:441-51
53. Bierhaus A, Fleming T, Stoyanov S, et al. Methylglyoxal modification of Nav1.8
facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neur-
opathy. Nat Med 2012;18:926-34
54. Zenker J, Ziegler D, Chrast R. Novel pathogenic pathways in diabetic
neuropathy. Trends Neurosci 2013;36:439-49
55. Thieme K, Turk DC, Flor H. Responder criteria for operant and cognitive–
behavioral treatment of fibromyalgia syndrome. Arthritis Rheum 2007;57:
830-6
56. Practice Guidelines for Chronic Pain Management. An updated report by the
American Society of Anesthesiologists Task Force On Chronic Pain
Management and the American Society of Regional Anesthesia and Pain
Medicine. Anesthesiology 2010;112:1-24
57. Fries JF. Compression of morbidity in the elderly. Vaccine 2000;18:1584-9
58. Blechman MB, Gelb AM. Aging and gastrointestinal physiology. Clin Geriatr
Med 1999;15:429-38
59. Gazit R, Weissman IL, Rossi DJ. Hematopoietic stem cells and the aging
hematopoietic system. Semin Hematol 2008;45:218-24
60. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab
Rev 2009;41:67-76
61. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo
Clin Proc 2003;78:1564-77
62. Fox C, Livingston G, Maidment ID, et al. The impact of anticholinergic
burden in Alzheimer’s Dementia – the Laser-AD study. Age Ageing
2011;40:730-5
63. Solomon DH, Rassen JA, Glynn RJ, et al. The comparative safety of analgesics
in older adults with arthritis. J Am Med Assoc 2010;170:1968-78
64. Solomon DH, Rassen JA, Glynn RJ, et al. The comparative safety of opioids for
nonmalignant pain in older adults. Arch Intern Med 2010;170:1979-86
65. Kinirons MT, O’Mahony MS. Drug metabolism and ageing. Br J Clin
Pharmacol 2004;57:540-4
66. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and
pharmacodynamics: basic principles and practical applications. Br J Clin
Pharmacol 2004;57:6-14
67. Tobias DE. Start low and go slow. Hospital Pharmacist 2003;38:634-6
68. Nakasato Y, Young RL. Geriatric rheumatology: a comprehensive approach.
New York: Springer-Verlag, 2011
69. American Geriatrics Society Panel on the Pharmacological Management of
Persistent Pain in Older Patients. Pharmacological management of persistent
pain in older patients. J Am Geriatr Soc 2009;57:1331-46
70. Devine EB, Hansen RN, Wilson-Norton JL, et al. The impact of computerized
provider order entry on medication errors in a multispecialty group practice.
J Am Med Inform Assoc 2010;17:78-84
71. Clegg A, Young JB. Which medications to avoid in people at risk of delirium:
a systematic review. Age Ageing 2011;40:23-9
72. Ofman JJ, MacLean CH, Straus WL, et al. A metaanalysis of severe
upper gastrointestinal complications of nonsteroidal antiinflammatory drugs.
J Rheumatol 2002;29:804-12
73. Boers M, Tangelder MJD, van Ingen H, et al. The rate of NSAID-induced
endoscopic ulcers increases linearly but not exponentially with age: a pooled
analysis of 12 randomised trials. Ann Rheum Dis 2007;66:417-18
74. Niccoli L, Bellino S, Cantini F. Renal tolerability of three commonly employed
non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritis.
Clin Exp Rheumatol 2002;20:201-7
75. Juhlin T, Bjo¨rkman S, Ho¨glund P. Cyclooxygenase inhibition causes marked
impairment of renal function in elderly subjects treated with diuretics and
ACE-inhibitors. Eur J Heart Fail 2005;7:1049-56
76. Pergolizzi J, Bo¨ger Rh, Budd K, et al. Opioids and the management of chronic
severe pain in the elderly: consensus statement of an international expert
panel with focus on the six clinically most often used World Health
Organization Step III opioids (buprenorphine, fentanyl, hydromorphone,
methadone, morphine, oxycodone). Pain Pract 2008;8:287-313
77. King SA. Chronic pain management in the elderly: an update on safe,
effective options. Consultant360 2012;52(5). Available at: http://www.
consultant360.com/article/chronic-pain-management-elderly-update-safe-
effective-options [Last accessed 11 February 2014]
78. Saunders KW, Dunn KM, Merrill JO, et al. Relationship of opioid use and
dosage levels to fractures in older chronic pain patients. J Gen Intern Med
2010;25:310-15
79. Buckeridge D, Huang A, Hanley J, et al. Risk of injury associated with opioid
use in older adults. J Am Geriatr Soc 2010;58:1664-70
80. Miller M, Stu¨rmer T, Azrael D, et al. Opioid analgesics and the risk
of fractures in older adults with arthritis. J Am Geriatr Soc 2011;59:430-8
81. Kinjo M, Setoguchi S, Schneeweiss S, et al. Bone mineral density in
subjects using central nervous system-active medications. Am J Med
2005;118:1414.e7-12
82. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complica-
tions of multiple chronic conditions in the elderly. Arch Intern Med
2002;162:2269-76
83. Ko¨hler GI, Bode-Bo¨ger SM, Busse R, et al. Drug–drug interactions in medical
patients: effects of in-hospital treatment and relation to multiple drug use.
Int J Clin Pharmacol Ther 2000;38:504-13
84. Elliott RA. Problems with medication use in the elderly: an Australian per-
spective. J Pharm Prac Res 2006;36:58-66
85. Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-
the-counter medications and dietary supplements among older adults in
the U.S. JAMA 2008;300:2867-78
86. Cascorbi I. Drug interactions – principles, examples and clinical conse-
quences. Dtsch Arztebl Int 2012;109:546-56
87. Fendrick M, Pan DE, Johnson DE. OTC analgesics and drug interactions:
clinical implications. Osteopath Med Prim Care 2008;2:2. doi:10.1186/
1750-4732-2-2
88. Vadivelu N, Hines RL. Management of chronic pain in the elderly: focus on
transdermal buprenorphine. Clin Interv Aging 2008;3:421-30
89. Botterman J, Criel N. Inappropriate use of high doses of transdermal fentanyl
at admission to a palliative care unit. Palliat Med 2011;25:111-16
90. Lynch T. Management of drug–drug interactions: considerations for spe-
cial populations – focus on opioid use in the elderly and long term care.
Am J Manag Care 2011;17:S293-8
91. Kneip C, Terlinden R, Beier H, et al. Investigations into the drug–drug inter-
action potential of tapentadol in human liver microsomes and fresh human
hepatocytes. Drug Metab Lett 2008;2:67-75
92. Salzman C. Medication compliance in the elderly. J Clin Psychiatry
1995;56(Suppl 1):18-22
93. DiMatteo MR. Social support and patient adherence to medical treatment: a
meta-analysis. Health Psychol 2004;23:207-18
94. Patton K, Meyers J, Lewis BE. Enhancement of compliance among patients
with hypertension. Am J Manag Care 1997;3:1693-8
95. MacDonald ET, MacDonald JB, Phoenix M. Improving drug compliance after
hospital discharge. Br Med J 1977;2:618-21
96. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med
2005;353:487-97
97. Castan˜o PM, Bynum JY, Andre´s R, et al. Effect of daily text messages on oral
contraceptive continuation: a randomized controlled trial. Obstet Gynecol
2012;119:14-20
98. Picone DM, Titler MG, Dochterman J, et al. Predictors of medication errors
among elderly hospitalized patients. Am J Med Qual 2008;23:115-27
99. Dennison RD. Creating an organizational culture for medication safety.
Nurs Clin N Am 2005;40:1-23
100. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order
entry and a team intervention on prevention of serious medication errors.
JAMA 1998;280:1311-16
101. Potts AL, Barr FE, Gregory DF, et al. Computerized physician order entry
and medication errors in a pediatric critical care unit. Pediatrics
2004;113:59-63
Current Medical Research & Opinion Volume 30, Number 6 June 2014
! 2014 Informa UK Ltd www.cmrojournal.com Managing chronic pain in elderly patients Kress et al. 1163
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 H
els
ink
i] 
at 
02
:52
 11
 Ja
nu
ary
 20
16
 
102. Poon EG, Cina JL, Churchill W, et al. Medication dispensing errors
and potential adverse drug events before and after implementing bar
code technology in the pharmacy. Ann Intern Med 2006;145:426-34
103. Brennan F, Carr DB, Cousins M. Pain management: a fundamental human
right. Anesth Analg 2007;105:205-21
104. Von Roenn JH, Cleeland CS, Gonin R, et al. Physician attitudes and practice
in cancer pain management: a survey from the Eastern Cooperative
Oncology Group. Ann Intern Med 1993;19:121-6
105. Vainio A. Treatment of terminal care pain in France: a questionnaire study.
Pain 1995;62:155-62
106. Survey of undergraduate pain curricula for healthcare professionals in
the United Kingdom: a short report. The Pain Education Special
Interest Group of the British Pain Society. London, UK: The British
Pain Society, 2009. Available at: http://www.britishpainsociety.org/
members_sig_edu_short_report_survey.pdf [Last accessed 8 May
2012]
Current Medical Research & Opinion Volume 30, Number 6 June 2014
1164 Managing chronic pain in elderly patients Kress et al. www.cmrojournal.com ! 2014 Informa UK Ltd
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 H
els
ink
i] 
at 
02
:52
 11
 Ja
nu
ary
 20
16
 
